Bertis

Private

Seongnam-siHealthcare & Life Scienceshttps://bertis.com/

Last Round

Private Equity

Feb 26, 2024

Est. Valuation

$109.56M

Total Funding Raised

$53.73M

Company Overview

Bertis is a biotechnology company that develops proteomics-based precision medicine technology and AI-driven diagnostic solutions for cancer and other major diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

proteomicsearly cancer detectionliquid biopsyprecision medicinebiomarker discoverymulti-omicsmedical AImass spectrometrydiagnostic testdrug target discoverybioinformaticsclinical diagnosticscancer screeningAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bertis Comps

Public and private peers based on sector, stage, and business model.

Bertis comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bertis Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	Feb 26, 2024
Corporate Funding	Jun 3, 2021
Series B	Dec 28, 2020
Series A	Oct 31, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Jayden P.

Chief Financial Officer & Co-founder

Founding Team

dong-young noh

Chief Executive Officer

Executive Team

Seungman Han

Chief Executive Officer

Executive Team

Bertis Investors

Notable investors and investment history

Bertis investors
Investor	Rounds
BNH INVESTMENT	Series B, Private Equity
Smilegate Investment	Series B, Series A
Focus Assets Management	Series B
KCLAVIS Investment	Series B
Korea Investment Partners	Series A
Winvest Venture Capital	Private Equity
Premier Partners	Series B, Private Equity

View all Investors

Bertis Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Bertis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bertis's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeongnam-si

Employee Range39

Year Founded2014

Last FundingFeb 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.